Dow University of Health Sciences   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Karachi Pakistan (1945)

Organization Overview

First Clinical Trial
2008
NCT01855763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Afshan Amjad Ali | Assistant professor at Dr.Ruth K.M pfau Civil Hospital Karachi,DUHS | Associate Professor Dow university of health sciences | Blood Diseases Clinic | DIKIOHS, DUHS | Dow International Dental College, Dow University of Health Sciences | Dow Ishrat ul Ebad Institute of Oral Health Sciences | dow university | dow university and health sciences | Dow University Hospital | Dow University Hospital, Mission Rd, Gulzar-e-Hijri, Scheme 33, Karachi. Tel: (92-21) 38771111 | Dow University of Health Science Karachi | Dow University of Health Sciences | Dow University of Health Sciences, Principal Dow College of Biotechnology | Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences Karachi, Pakistan | Dr. Ruth KM Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan | Dr. Ruth K. M. Pfau, Civil hospital Karachi | Head of Community Department, Dow University of Health Sciences, Karachi, Pakistan | Juzer Shabbir Saifee | Nomi Waqas Gul | Sana Urooj | School of Public Health, Dow University of Health Sciences, Karachi, Pakistan | Senior Lecturer, DUHS, Karachi

Active Ingredients

Drugs in Phase 4 Trials (17)

allopurinol (zyloprim) (1 trial)

amoxicillin (3 trials)

bupivacaine (Exparel) (2 trials)

calcium (2 trials)

clarithromycin (biaxin) (1 trial)

dexamethasone (2 trials)

dexmedetomidine (precedex) (5 trials)

empagliflozin (jardiance) (1 trial)

ergocalciferol (drisdol) (1 trial)

febuxostat (uloric) (1 trial)

gabapentin (neurontin) (1 trial)

omeprazole (prilosec) (1 trial)

phosphate (1 trial)

sodium fluoride (1 trial)

vildagliptin (1 trial)

vitamin d3 (4 trials)

vonoprazan (Voquezna) (1 trial)

Drugs in Phase 3 Trials (25)

calcium hydroxide (1 trial)

carvedilol (coreg) (1 trial)

celecoxib (celebrex) (1 trial)

cephalexin (keflex) (1 trial)

chlorhexidine (hibitane) (1 trial)

covid 19 immune globulin (1 trial)

edetic acid (1 trial)

escitalopram (lexapro) (1 trial)

hydralazine (apresoline) (1 trial)

hypochlorous acid (2 trials)

insulin human (humulin) (1 trial)

labetalol (trandate) (2 trials)

metronidazole (flagyl) (3 trials)

minocycline (minocin) (1 trial)

naproxen (naprosyn) (1 trial)

nifedipine (procardia) (1 trial)

piroxicam (feldene) (1 trial)

prednisolone (hydeltra) (1 trial)

propolis (5 trials)

sertraline (zoloft) (1 trial)

sitagliptin (januvia) (1 trial)

sodium fluoride (18F) (2 trials)

strontium acetate (1 trial)

tramadol (Ultram) (1 trial)

zinc sulfate (1 trial)

Drugs in Phase 2 Trials (9)

epinephrine (levophed) (4 trials)

jinhua qinggan (1 trial)

mepivacaine (carbocaine) (1 trial)

metformin (glucophage) (1 trial)

ondansetron (zofran) (2 trials)

pioglitazone (actos) (1 trial)

povidone-iodine (betadine) (1 trial)

simvastatin (zocor) (2 trials)

thalidomide (Thalomid) (1 trial)

Drugs in Phase 1 Trials (8)

benzocaine (Orajel) (1 trial)

COVID-19 convalescent plasma (1 trial)

etoricoxib (Gencox) (1 trial)

folic acid (1 trial)

lidocaine (xylocaine) (4 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

naltrexone (revia) (1 trial)

prilocaine (citanest) (1 trial)

Drugs in Other Trials (18)

acetaminophen (tylenol) (1 trial)

aloe vera (1 trial)

bupropion (wellbutrin) (1 trial)

chlorinated lime (1 trial)

ethylenediamine (2 trials)

etidronic acid (1 trial)

fentanyl (Innovar) (3 trials)

ferric derisomaltose (Monoferric) (1 trial)

ferrous sulfate (1 trial)

honey (2 trials)

hydrogen peroxide (1 trial)

malic acid (1 trial)

sapindus mukorossi (1 trial)

sodium chloride (2 trials)

sodium phosphate (1 trial)

sofosbuvir (sovaldi) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

velpatasvir (Epclusa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 3)

Cerebral Infarction (Phase 1)

Chronic Periodontitis (Phase 3)

Dental Pulp Diseases (Phase 3)

Dentin Sensitivity (Phase 3)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Disease (Phase 3)

Dry Socket (Phase 2)

Dysgeusia (Phase 3)

Eclampsia (Phase 3)

Hand Injuries (Phase 4)

Hydropneumothorax (Phase 2)

Hyperandrogenism (Phase 2)

Hypersensitivity (Phase 3)

Hypertension (Phase 3)

Hypertension, Portal (Phase 3)

Hypertension, Pregnancy-Induced (Phase 3)

Hyperuricemia (Phase 4)

Infections (Phase 3)

Irritable Bowel Syndrome (Phase 4)

Ischemia (Phase 1)

Menstruation Disturbances (Phase 2)

Mood Disorders (Phase 3)

Pain, Postoperative (Phase 3)

Periodontal Diseases (Phase 3)

Periodontitis (Phase 3)

Pneumothorax (Phase 2)

Pre-Eclampsia (Phase 3)

Pregnancy in Diabetics (Phase 3)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Severe Acute Respiratory Syndrome (Phase 1)

Stroke (Phase 1)

Surgical Wound Infection (Phase 3)

Thalassemia (Phase 2)

Tooth, Impacted (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 64
  • # of Trial APIs: 77